Aaron L. Magno

1.6k total citations
32 papers, 1.2k citations indexed

About

Aaron L. Magno is a scholar working on Molecular Biology, Ophthalmology and Nephrology. According to data from OpenAlex, Aaron L. Magno has authored 32 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 10 papers in Ophthalmology and 7 papers in Nephrology. Recurrent topics in Aaron L. Magno's work include Retinal Diseases and Treatments (10 papers), Parathyroid Disorders and Treatments (7 papers) and Retinal Development and Disorders (7 papers). Aaron L. Magno is often cited by papers focused on Retinal Diseases and Treatments (10 papers), Parathyroid Disorders and Treatments (7 papers) and Retinal Development and Disorders (7 papers). Aaron L. Magno collaborates with scholars based in Australia, United States and United Kingdom. Aaron L. Magno's co-authors include Bryan K. Ward, Thomas Ratajczak, Elizabeth Rakoczy, Chooi‐May Lai, Ian J. Constable, Mark S. Blumenkranz, Mariapia A. Degli‐Esposti, Martyn A. French, Markus P. Schlaich and Steven D. Schwartz and has published in prestigious journals such as The Lancet, Blood and Endocrine Reviews.

In The Last Decade

Aaron L. Magno

32 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aaron L. Magno Australia 17 642 341 213 177 164 32 1.2k
Franziska vom Hagen Germany 17 628 1.0× 493 1.4× 84 0.4× 197 1.1× 37 0.2× 24 1.3k
J. M. B. Bloodworth United States 24 373 0.6× 287 0.8× 355 1.7× 178 1.0× 128 0.8× 47 1.6k
Yun Yan United States 18 379 0.6× 107 0.3× 81 0.4× 100 0.6× 12 0.1× 57 858
Kan Koizumi Japan 13 610 1.0× 1.5k 4.3× 103 0.5× 793 4.5× 30 0.2× 17 2.2k
Rosalia D’Angelo Italy 26 661 1.0× 297 0.9× 21 0.1× 145 0.8× 25 0.2× 71 1.3k
Xiu‐Miao Li China 21 1.7k 2.7× 304 0.9× 44 0.2× 106 0.6× 15 0.1× 57 2.3k
Jinqiao Qian China 21 755 1.2× 55 0.2× 84 0.4× 39 0.2× 26 0.2× 42 1.3k
Alba Casellas Spain 20 569 0.9× 116 0.3× 360 1.7× 65 0.4× 16 0.1× 30 1.3k
Shinichiro J. Tojo Japan 19 568 0.9× 124 0.4× 17 0.1× 49 0.3× 50 0.3× 40 1.1k
Ema Ozaki Ireland 14 766 1.2× 470 1.4× 13 0.1× 147 0.8× 44 0.3× 23 1.3k

Countries citing papers authored by Aaron L. Magno

Since Specialization
Citations

This map shows the geographic impact of Aaron L. Magno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aaron L. Magno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aaron L. Magno more than expected).

Fields of papers citing papers by Aaron L. Magno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aaron L. Magno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aaron L. Magno. The network helps show where Aaron L. Magno may publish in the future.

Co-authorship network of co-authors of Aaron L. Magno

This figure shows the co-authorship network connecting the top 25 collaborators of Aaron L. Magno. A scholar is included among the top collaborators of Aaron L. Magno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aaron L. Magno. Aaron L. Magno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Magno, Aaron L., Lakshini Y. Herat, Márcio Galindo Kiuchi, et al.. (2020). The Influence of Hypertensive Therapies on Circulating Factors: Clinical Implications for SCFAs, FGF21, TNFSF14 and TNF-α. Journal of Clinical Medicine. 9(9). 2764–2764. 4 indexed citations
3.
Herat, Lakshini Y., Aaron L. Magno, Caroline Rudnicka, et al.. (2020). SGLT2 Inhibitor–Induced Sympathoinhibition. JACC Basic to Translational Science. 5(2). 169–179. 166 indexed citations
4.
Magno, Aaron L., et al.. (2020). Functional Analysis of Calcium-Sensing Receptor Variants Identified in Families Provisionally Diagnosed with Familial Hypocalciuric Hypercalcaemia. Calcified Tissue International. 107(3). 230–239. 4 indexed citations
5.
Herat, Lakshini Y., Natalie C. Ward, Aaron L. Magno, et al.. (2020). Sodium glucose co-transporter 2 inhibition reduces succinate levels in diabetic mice. World Journal of Gastroenterology. 26(23). 3225–3235. 18 indexed citations
6.
Rakoczy, Elizabeth, Aaron L. Magno, Chooi‐May Lai, et al.. (2019). Three-Year Follow-Up of Phase 1 and 2a rAAV.sFLT-1 Subretinal Gene Therapy Trials for Exudative Age-Related Macular Degeneration. American Journal of Ophthalmology. 204. 113–123. 51 indexed citations
7.
Herat, Lakshini Y., et al.. (2019). The Schlager mouse as a model of altered retinal phenotype. Neural Regeneration Research. 15(3). 512–512. 7 indexed citations
8.
Ward, Bryan K., Sarah L. Rea, Aaron L. Magno, et al.. (2017). The endoplasmic reticulum‐associated protein, OS‐9, behaves as a lectin in targeting the immature calcium‐sensing receptor. Journal of Cellular Physiology. 233(1). 38–56. 5 indexed citations
9.
Constable, Ian J., Chooi‐May Lai, Aaron L. Magno, et al.. (2017). Gene Therapy in Neovascular Age-related Macular Degeneration: Three-Year Follow-up of a Phase 1 Randomized Dose Escalation Trial. American Journal of Ophthalmology. 177. 150–158. 64 indexed citations
10.
Rakoczy, Elizabeth, Chooi‐May Lai, Aaron L. Magno, et al.. (2016). Association of serum neutralizing antibodies with safety and efficacy outcomes in a Phase 2a trial of rAAV.sFlt-1 in the treatment of wet AMD. 57(12). 526–526. 1 indexed citations
11.
McLenachan, Samuel, Aaron L. Magno, David Ramos‐Barbón, et al.. (2015). Angiography reveals novel features of the retinal vasculature in healthy and diabetic mice. Experimental Eye Research. 138. 6–21. 52 indexed citations
12.
Rakoczy, Elizabeth, Chooi‐May Lai, Aaron L. Magno, et al.. (2015). Gene therapy with recombinant adeno-associated vectors for neovascular age-related macular degeneration: 1 year follow-up of a phase 1 randomised clinical trial. The Lancet. 386(10011). 2395–2403. 147 indexed citations
13.
Wisniewska‐Kruk, Joanna, Ingeborg Klaassen, Ilse M. C. Vogels, et al.. (2014). Molecular analysis of blood–retinal barrier loss in the Akimba mouse, a model of advanced diabetic retinopathy. Experimental Eye Research. 122. 123–131. 66 indexed citations
14.
Ward, Bryan K., Aaron L. Magno, John P. Walsh, & Thomas Ratajczak. (2012). The role of the calcium-sensing receptor in human disease. Clinical Biochemistry. 45(12). 943–953. 76 indexed citations
15.
Magno, Aaron L., Evan Ingley, Suzanne J. Brown, et al.. (2011). Testin, a novel binding partner of the calcium-sensing receptor, enhances receptor-mediated Rho-kinase signalling. Biochemical and Biophysical Research Communications. 412(4). 584–589. 10 indexed citations
16.
Arulpragasam, Ajanthy, Aaron L. Magno, Evan Ingley, et al.. (2011). The adaptor protein 14-3-3 binds to the calcium-sensing receptor and attenuates receptor-mediated Rho kinase signalling. Biochemical Journal. 441(3). 995–1007. 20 indexed citations
17.
18.
Ward, Bryan K., Fergus Cameron, Aaron L. Magno, et al.. (2006). A Novel Homozygous Deletion in the Calcium-Sensing Receptor Ligand-Binding Domain Associated with Neonatal Severe Hyperparathyroidism. Journal of Pediatric Endocrinology and Metabolism. 19(1). 93–100. 2 indexed citations
19.
Ward, Bryan K., Aaron L. Magno, Bradley J. Blitvich, et al.. (2006). Novel mutations in the calcium‐sensing receptor gene associated with biochemical and functional differences in familial hypocalciuric hypercalcaemia. Clinical Endocrinology. 64(5). 580–587. 30 indexed citations
20.
Ward, Bryan K., Aaron L. Magno, Elizabeth A. Davis, et al.. (2004). Functional Deletion of the Calcium-Sensing Receptor in a Case of Neonatal Severe Hyperparathyroidism. The Journal of Clinical Endocrinology & Metabolism. 89(8). 3721–3730. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Franziska vom Hagen Breakdown of academic impact, for papers by J. M. B. Bloodworth Breakdown of academic impact, for papers by Yun Yan Breakdown of academic impact, for papers by Kan Koizumi Breakdown of academic impact, for papers by Rosalia D’Angelo Breakdown of academic impact, for papers by Xiu‐Miao Li Breakdown of academic impact, for papers by Jinqiao Qian Breakdown of academic impact, for papers by Alba Casellas Breakdown of academic impact, for papers by Shinichiro J. Tojo Breakdown of academic impact, for papers by Ema Ozaki
Rankless by CCL
2026